CIK: 0000938582 · Show all filings
Period: Q3 2015 (← Previous) (Next →)
Filing Date: Nov 13, 2015
Total Value: $324M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| JPM | VANGUARD MSCI EMERGING MARKETS ETF | 3,410,000 | $113M | 34.8% | $49.62 | 0.0% | ETF | 46625H100 |
| FXI | I SHARES MSCI EAFE INDEX FD | 1,895,400 | $109M | 33.5% | $57.32 | — | COM | 464287184 |
| ESMC | ISHARES FTSE/XINHUA CHINA 25 INDEX FUND | 2,703,700 | $95.9M | 29.6% | $1.31 | 0.0% | COM | 296074305 |
| — | PALO ALTO NETWORKS INC | 33,927 | $5.835M | 1.8% | $171.99 | — | COM | 46121H109 |
| — | ATARA BIOTHERAPEUTICS INC | 9,260 | $291K | 0.1% | $31.43 | — | COM | 046513107 |
| IRWD | TESARO INC | 6,238 | $250K | 0.1% | $9.33 | 0.0% | COM | 46333X108 |
| EFA | JPMORGAN CHASE & CO | 4,000 | $244K | 0.1% | $63.21 | — | ETF | 464287465 |
| CORT | CORCEPT THERAPEUTICS INC | 22,334 | $84,000 | 0.0% | $5.07 | 0.0% | COM | 218352102 |